Clinical usefulness of <sup>18</sup><scp>F</scp>‐fluorodeoxyglucose positron emission tomography/computed tomography for patients with primary liver cancer with special reference to rare histological types, hepatocellular carcinoma with sarcomatous change and combined hepatocellular and cholangiocarcinoma
Hideki Ijichi(Kyushu University), Yoshihiko Maehara(Kyushu University), Youhei Mano(Kyushu University), Tomoharu Yoshizumi(Kyushu University), Toru Ikegami(Jikei University School of Medicine), Akinobu Taketomi(Hokkaido University), Hiroshi Honda(Kyushu University), Koichiro Abe(Kyushu University), Shinichi Aishima(Saga University), Ken Shirabe(Gunma University)
Cited by 34
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality
|American Journal of Respiratory and Critical Care Medicine|2019|260
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244